AIMC Topic: Virus Shedding

Clear Filters Showing 1 to 3 of 3 articles

Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding.

Journal of translational medicine Nov 22, 2024
BACKGROUND: The global outbreak of the coronavirus disease 2019 (COVID-19) has been enormously damaging, in which prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously 2019-nCoV) infection is a challenge in the...
Humans Machine Learning COVID-19 Retrospective Studies Female SARS-CoV-2 Risk Factors Aged Young Adult Adult Male Middle Aged China Adolescent Time Factors Virus Shedding
View on PubMed DOI

An inactivated influenza D virus vaccine partially protects cattle from respiratory disease caused by homologous challenge.

Veterinary microbiology Dec 21, 2016
Originally isolated from swine, the proposed influenza D virus has since been shown to be common in cattle. Inoculation of IDV to naïve calves resulted in mild respiratory disease histologically characterized by tracheitis. As several studies have as...
Animals Viral Vaccines Viral Load Cattle Cattle Diseases Antibodies, Viral Vaccination Vaccines, Inactivated Antigens, Viral Bovine Respiratory Disease Complex Orthomyxoviridae Infections Thogotovirus Virus Shedding
View on PubMed DOI

An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study.

Science translational medicine May 14, 2025
There are currently no licensed vaccines for norovirus, a leading cause of epidemic and endemic gastroenteritis worldwide. Clinical advancement of promising vaccine candidates from phase 2 studies to phase 3 field trials has been hampered by the lack...
Humans Female Young Adult Adult Male Viral Vaccines Feces Antibodies, Viral Vaccination Administration, Oral Gastroenteritis Virus Shedding Immunoglobulin A Caliciviridae Infections Norovirus Placebos Immunity, Mucosal
View on PubMed DOI
Popular Topics
Recent Journals